It says “no cross pathy practise is allowed by any medical practitioner unless such person is also registered in that system in which he is practising.”
According to the order, drugs that are commonly prescribed include LIV52 and Amlycure DS for liver problems; Cystone for kidney stones; Septilin for better immunity; M2 Tone for polycystic ovarian disorder and other ovarian and fertility problems; Neeri for urinary problems and kidney stones; and Amycordial for women’s health.
The order also states that practising cross pathy can be punishable by rigorous imprisonment of up to three years and a fine of up to Rs 50,000 under the Delhi Bhartiya Chikitsa Parishad Act of 1998. The order have been released in newsletters produced by the Delhi Medical Association (DMA).
Dr Anil Bansal, chairperson of the anti-quackery cell of DMC, said, “It has become increasingly common for general practitioners and specialists in several established hospitals to prescribe ayurvedic drugs as an adjuvant — to improve the efficacy of allopathic drugs
Doctors said the trend could have been fuelled by several drug companies entering the market in the past few years. A senior gastroenterologist in Delhi said, “LIV52 is prescribed routinely to patients with hepatic disorders because it provides a long-term efficacy to allopathic drugs and boosts their outcome. Several international studies have also established this and practitioners are using it abroad. It is also available over the counter, so I do not understand the need for such orders. Besides, we don’t prescribe ayurvedic drugs as standalone options.”
Dr Bansal said “Just as the Medical Council of India Act prohibits specialists from traditional systems of medicine to practise allopathic drugs, the Delhi Bhartiya Chikitsa Parishad Act bans doctors with degrees in modern medicine to prescribe traditional drugs,” he said.[Source]